Weidong Li

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial

Shun Lü, Jie Wang, Yan Yu et al. · Journal of Thoracic Oncology · 2021 · 264 citations · Full text

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 253 citations · Full text

Genome Scan for Human Obesity and Linkage to Markers in 20q13

Joseph H. Lee, Danielle R. Reed, Weidong Li et al. · The American Journal of Human Genetics · 1999 · 239 citations · Full text

Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study

Xiaoxu Huo, Leili Gao, Lixin Guo et al. · The Lancet Diabetes & Endocrinology · 2015 · 235 citations

Diabetes Epidemiology, Cardiovascular Epidemiology, Cardiovascular Disease +8

A Genome-Wide Association Study on Obesity and Obesity-Related Traits

Kai Wang, Weidong Li, Zuoheng Wang et al. · PLoS ONE · 2011 · 225 citations · Full text